These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 7250812)

  • 1. Lymphocyte marker testing in relation to the clinical use of dialyzed leukocyte extract containing transfer factor (DLE-LTF).
    Peetoom F; Florey MJ
    Haematologia (Budap); 1980; 13(1-4):225-37. PubMed ID: 7250812
    [No Abstract]   [Full Text] [Related]  

  • 2. Guidelines for immunotherapy of antigen-specific defects with transfer factor.
    Wilson GB; Fudenberg HH; Keller RH
    J Clin Lab Immunol; 1984 Feb; 13(2):51-8. PubMed ID: 6202873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transfer factor treatment of viral diseases.
    Khan A
    Cutis; 1979 Oct; 24(4):360, 379, 451 passim. PubMed ID: 509979
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment with transfer factor of herpes zoster varicella infection in Hodgkin's disease.
    Silvino G; Rubertelli M; Cristofolini M; Sagramoso Z; Pisciolli F; Dalri P
    Haematologica; 1978 Feb; 63(1):56-60. PubMed ID: 417972
    [No Abstract]   [Full Text] [Related]  

  • 5. "Discoid" lupus erythematosus: dramatic clinical and immunological response to dialyzable leukocyte extract (transfer factor).
    Fudenberg HH; Strelkauskas AJ; Goust JM; Osborne D; Fort D; Vasily D
    Trans Assoc Am Physicians; 1981; 94():279-91. PubMed ID: 6979820
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of dialyzable leukocyte extracts (DLE) and inosine on stimulated lymphocytes.
    Komatsu F
    Bull Tokyo Med Dent Univ; 1989 Sep; 36(3):35-40. PubMed ID: 2632132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dialyzable leukocyte extract differentially regulates the production of TNFalpha, IL-6, and IL-8 in bacterial component-activated leukocytes and endothelial cells.
    Ojeda MO; van't Veer C; Fernández Ortega CB; Araña Rosainz Mde J; Buurman WA
    Inflamm Res; 2005 Feb; 54(2):74-81. PubMed ID: 15750714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adult chronic granulomatosis disease-like neutrophil granulocyte disorder corrected by dialysable leukocyte extract.
    Lukács K; Szabó G; Schröder I; Szegedi G
    Allergol Immunopathol (Madr); 1988; 16(2):121-5. PubMed ID: 3394593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Studies on effect of a specific transfer factor on Japanese encephalitis virus infection in mice].
    Wang FZ; Huang ZX
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1983 Apr; 5(2):102-6. PubMed ID: 6313238
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of anti-herpes specific transfer factor.
    Byston J; Cech K; Pekarek J; Jilkova J
    Biotherapy; 1996; 9(1-3):73-5. PubMed ID: 8993761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Therapy of herpes zoster uring active premunization. 1. Therapeutic possibilities: bases and the principle of premunition--premunization].
    Mayr A; Stickl H; Westhues M; Gillesberger W; Schwarz D; Bibrack B
    Fortschr Med; 1977 Jan; 95(2):87-93. PubMed ID: 832835
    [No Abstract]   [Full Text] [Related]  

  • 12. Transfer factor and its clinical application.
    Schulkind ML; Ayoub EM
    Adv Pediatr; 1980; 27():89-115. PubMed ID: 7013447
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of corneal herpes with lymphocyte extract dialysates (preliminary study)].
    Vignat JP; Hainaut J; Bourgeois H
    Bull Soc Ophtalmol Fr; 1978; 78(8-9):551-4. PubMed ID: 751750
    [No Abstract]   [Full Text] [Related]  

  • 14. Transfer factor.
    Massicot JG; Goldstein RA
    Ann Allergy; 1982 Dec; 49(6):326-9. PubMed ID: 7149349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transfer factor: specific and nonspecific effects and chemical characteristics of dialyzable leukocyte lysates (DLL). Part II. Reconstituting effects dialyzable leukocyte lysates. (Second of three parts).
    Schindler TE; Baram P
    Allergol Immunopathol (Madr); 1980; 8(2):125-9. PubMed ID: 7457287
    [No Abstract]   [Full Text] [Related]  

  • 16. [Dialyzed leukocyte extracts for the treatment of recurrent and severe infections in pediatric patients with cellular immunodeficiency: 15 years of experience].
    Ayala MC; González NM; Palacios G; Rivera-Morales LG; Rodríguez-Padilla C
    Rev Alerg Mex; 2019; 66(1):27-37. PubMed ID: 31013404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New and cost effective cell-based assay for Dialyzed Leukocyte Extract (DLE)-induced Jurkat cells proliferation under azathioprine treatment.
    Cardoso FM; Tomkova M; Petrovajova D; Bubanova M; Ragac O; Hornakova T
    J Pharm Biomed Anal; 2017 May; 138():100-108. PubMed ID: 28189890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transfer factor--a lymphocyte cell surface component.
    Schröder I; Lüneburg S
    Allergol Immunopathol (Madr); 1984; 12(1):1-5. PubMed ID: 6731201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transfer factor treatment of patients with multuple sclerosis. I. Preliminary report of changes in immunological parameters.
    Jersild C; Platz P; Thomsen M; Dupont B; Svejgaard A; Ciongoli AK; Fog T; Grob P
    Scand J Immunol; 1976; 5(1-2):141-8. PubMed ID: 178047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic pulmonary histoplasmosis: improved lymphocyte response with transfer factor.
    Smith CR; Griffin DE; Graybill JR
    Ann Intern Med; 1976 Jun; 84(6):708-9. PubMed ID: 937885
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.